Results 191 to 200 of about 1,240,733 (309)

Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases. [PDF]

J Clin Med
Biskupiak Z, Ha VV, Rohaj A, Bulaj G.
europepmc   +1 more source

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis. [PDF]

Front Pharmacol, 2018
Manova M, Savova A, Vasileva M, Terezova S, Kamusheva M, Grekova D, Petkova V, Petrova G.   +7 more
europepmc   +1 more source

Synthesis of phenolic natural products of biological interest

, 2004
Satish Chand
openalex   +1 more source

Biological Interesting Products [PDF]

Chemical & Engineering News Archive, 2014
openaire   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products.

Biologicals
Feavers I, Lei D, Milne C, Knezevic I, Zhou T, Kim E.   +5 more
europepmc   +1 more source

Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: "Drug Products, Including Biological Products, that Contain Nanomaterials". [PDF]

AAPS J, 2019
de Vlieger JSB, Crommelin DJA, Tyner K, Drummond DC, Jiang W, McNeil SE, Neervannan S, Crist RM, Shah VP.   +8 more
europepmc   +1 more source

Biological properties of Stevia sweetener and egg replacers' products on serum biochemical markers of diabetic rats

, 2013
Hend H. A. Junbi, Afaf Hamza Basheer Amer   +1 more
openalex   +2 more sources

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source

Removal of the innocuity test from The International Pharmacopoeia and WHO recommendations for vaccines and biological products.

Biologicals, 2020
Lei D, Schmidt H, Knezevic I, Zhou T, Kang HN, Kopp S.   +5 more
europepmc   +1 more source